qRT-PCR was used to detect the RNA expression of METTL14 and miR-1306-5p. All the RNA was collected from blood, cell, or tissue samples using the
miRNeasy extraction kit (QIAGEN). For quantitative analysis, the cDNA was reversed by
miRNA Reverse Transcription Kit (MR101-01/02, Vazyme) and detected by all-in-one miRNA RT-qPCR Detection Kit (Q711-02, Vazyme) with U6 as the internal control. As for METTL14 mRNA detection,
TRIzol (BS259A, Biosharp) was used for RNA isolation and
PrimeScript RT Reagent kit (R223-01, Vazyme) was used to reverse RNA into cDNA.
SYBR Green Real-Time PCR Master Mix (Q711-02, Vazyme) was used for RT-PCR assay with
β-actin as the control. The primers for miR-1306-5p, U6, METTL14, and
β-actin were listed as below: METTL14, sense, 5′- GAGTGTGTTTACGAAAATGGGGT-3′; antisense, 5′- CCGTCTGTGCTACGCTTCA-3′;
β-actin: sense, 5′-AGCGAGCATCCCCCAAAGTT-3′, antisense: 5′-GGGCACGAAGGCTCATCATT-3′; U6: sense, 5′-CTCGCTTCGGCAGCACA-3′, antisense: 5′-AACGCTTCACGAATTTGCGT-3′; miR-1306-5p reverse primer: 5′-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTGGACGTT-3′; miR-1306-5p sense: 5′-AATACCACCTCCCCTGCA-3′. 2
−ΔΔCt method was used for analysis of relative expression.
Li J., Wu Y., Wang M., Chen X., Li Z., Bai X, & Wu H. (2022). MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia. Computational and Mathematical Methods in Medicine, 2022, 5787808.